839 results on '"San-Miguel, J. F."'
Search Results
52. Antibiotic prophylaxis with meropenem after allogeneic stem cell transplantation
53. Abnormalities on 1q and 7q are associated with poor outcome in sporadic Burkitt's lymphoma. A cytogenetic and comparative genomic hybridization study
54. Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications
55. Incomplete DJH rearrangements as a novel tumor target for minimal residual disease quantitation in multiple myeloma using real-time PCR
56. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities
57. Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning
58. Risk factors for thrombotic microangiopathy in allogeneic haematopoietic stem cell recipients receiving graft-versus-host disease prophylaxis with tacrolimus plus methotrexate or sirolimus: O372
59. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group
60. Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients
61. Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use
62. Frequency of HLA-A, -B and -DRB1 specificities and haplotypic associations in the population of Castilla y León (northwest-central Spain)
63. The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkinʼs lymphoma
64. Bisphosphonate-related osteonecrosis: genetic and acquired risk factors
65. Sequential intravenous-oral ciprofloxacin plus amoxycillin/clavulanic acid shortens hospital stay in infected non severe neutropenic patients
66. The presence of DRB1*01 allele in multiple myeloma patients is associated with an indolent disease
67. Low expression of ZHX2, but not RCBTB2 or RAN, is associated with poor outcome in multiple myeloma
68. Predicting long-term disease control in transplant-ineligible patients with multiple myeloma: impact of an MGUS-like signature
69. Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma
70. 6q deletion in Waldenström macroglobulinemia is associated with features of adverse prognosis
71. Expression of APO2.7, bcl-2 and bax apoptosis-associated proteins in CD34− bone marrow cell compartments from patients with myelodysplastic syndromes
72. Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma
73. Tuberculous arachnoiditis after a second allogeneic haematopoietic stem cell transplantation for acute lymphoblastic leukemia in CR2
74. TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells
75. Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy
76. Lymphoid subsets in acute myeloid leukemias: Increased number of cells with NK phenotype and normal T-cell distribution
77. Randomized comparison of dexamethasone combined with melphalan versus melphalan with prednisone in the treatment of elderly patients with multiple myeloma
78. Quality of life assessment in patients undergoing reduced-intensity conditioning allogeneic transplantation
79. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic haematopoietic stem cell transplantation
80. Clonality analysis in malignant lymphoma: the BIOMED-2 experience
81. Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkinʼs disease
82. Cidofovir treatment of human polyomavirus-associated acute haemorrhagic cystitis
83. Immunophenotypic Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia
84. Methods for Detection of Minimal Residual Disease
85. Monocyte counts: an early index of haemopoietic reconstitution after peripheral blood stem cell transplantation
86. SOME LIMITATIONS IN THE DETECTION OF RESIDUAL ANEUPLOID CELLS WITH DNA QUANTIFICATION ON IMMUNOPHENOTYPED CELLS BY FLOW CYTOMETRY
87. Allogeneic peripheral stem cell transplantation in a case of hereditary sideroblastic anaemia
88. Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage− cells
89. Low frequency of the TEL/AML1 fusion gene in acute lymphoblastic leukaemia in Spain
90. Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL
91. Prevention and management of adverse events of novel agents in multiple myeloma: A consensus of the European Myeloma Network
92. In vitro growth in acute myeloblastic leukaemia: relationship with other clinico-biological characteristics of the disease
93. IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases
94. Diagnostic and Prognostic Importance of Immunophenotyping in Adults with Acute Myeloid Leukemia
95. Multiparameter Analysis of Blast Cells in Patients with Acute Leukemia Following a Primary Myelodysplastic Syndrome
96. IMMUNOPHENOTYPE AND DNA PLOIDY ANALYSIS: IMPLICATIONS FOR MINIMAL RESIDUAL DISEASE INVESTIGATION IN MULTIPLE MYELOMA
97. DELETIONS AND REARRANGEMENTS OF CYCLIN-DEPENDENT KINASE 4 INHIBITOR GENE P16 ARE ASSOCIATED WITH POOR PROGNOSIS IN B-CELL NON-HODGKIN'S LYMPHOMAS
98. Expression of the CD117 antigen (C-Kit) on normal and myelomatous plasma cells
99. A randomized study comparing the effect of GM-CSF and G-CSF on immune reconstitution after autologous bone marrow transplantation
100. DETECTION OF MONOCLONALITY IN BONE MARROW PLASMA CELLS BY FLOW CYTOMETRY: LIMITATIONS FOR MINIMAL RESIDUAL DISEASE DETECTION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.